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Toward a Better Understanding of...

Elucidating the Role of a Lysyl Oxidase
Polymorphism in Risk for Coronary
Artery Disease
Sofia Luna and Salwa Mikhail
Mentor: Nathan Stitziel
Cardiovascular disease (CVD) is the leading cause of mortality in the United States and is
heritable. Identifying human genetic differences associated with CVD such as coronary
artery disease (CAD) has the potential to identify genes and pathways with direct
relevance to disease. Functional studies can then be used to discover the mechanisms
through which these genes affect the heart and vasculature. Recent studies have robustly
associated a naturally occurring human genetic polymorphism (R158Q) in the gene
lysyl oxidase (LOX) with increased risk of CAD. LOX is synthesized intracellularly and
then released into the ECM where it is cleaved into a pro-peptide and an enzymatic
peptide. The polymorphism in LOX alters the coding sequence of the pro-peptide
region of the gene, leading us to question whether the increase in atherosclerosis is due
to altered enzymatic activity of the protein or from altered function of the pro-peptide
itself. To study this, we cloned murine Lox cDNA into the pCMV6-Myc-His vector and
used site-directed mutagenesis to insert the mutation of interest at site 152, which is
the analogous position in murine Lox corresponding to amino acid 158 in human LOX.
We then subcloned the pro-peptide regions of both wild-type and 152Q Lox. Next,
we were able to transfect PP-Lox into cultured cells and purify each protein from the
media. We are assessing whether the PP-Lox polymorphism affects cell growth in a BrdU
proliferation assay. To determine if the PP-Lox polymorphism altered enzymatic activity,
we are performing an activity assay with the purified full length wild-type and 152Q Lox
proteins. We hypothesize that intracellular signaling in proliferation pathways will be
altered in the 152Q PP-Lox when compared to the wild-type while the enzymatic activity
will be unchanged. By studying the genetic basis of CAD our findings have the potential
to reveal novel biology and new therapeutic targets.
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